Dylan Essner on Documentation Tools for CAR T-Cell Therapy

News
Article

Dylan Essner discussed the implementation of documentation tools and CRS, ICANS and ICE flow sheets within CAR T-cell therapy.

Dylan Essner, an Epic Beacon Analyst at Washington University in St. Louis, talked about his work in implementing new documentation tools to streamline data for patients.

Transcription:

Within the CAR T(-cell) build in Epic, I helped mainly with the documentation tools for flow sheets. We have the CRS, ICANS and the ICE flow sheets, and I built all 3 of those flow sheets and included them in 1 flow sheet template that way the providers and nurses can go in and document their ICE, ICANS and CRS documentation. And then some of those--the ICANS and the ICE--have a formula built into the flow sheets that allows it to auto-populate the grade and score of the actual documentation. They just put in the different data points for each flow sheet and then we have a row at the bottom that auto-calculates the grade for each patient, so they don’t have to go in and do that.

And then for CRS they actually have to go in and we give them an informational chart they can look at, and then from there they can grade the patient from the bottom row. With that flow sheet data, we also built some smart links that pull the data from those flow sheets into the progress notes, so it automatically just populates into their progress notes making documentation for them a lot easier.

Recent Videos
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
A consolidated database may allow providers to access information on a patient’s prior treatments and genetic abnormalities all in 1 place.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Physical therapists may play a key role in patient care before, during, and after treatment for cancer, according to Alison Ankiewicz, PT, DPT.
Related Content